FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to compounds of formula (I) 
where R1 represents 
or 
and values of R2, R3 and R4 radicals are given in the invention formula, as well as to pharmaceutical compositions based on said compounds.
EFFECT: compounds of formula (I) and based on them compositions can be applied for treatment of cancer diseases: both solid tumours and hematologic cancers, such as leukemia, lymphoma and multiple myelomas.
11 cl, 10 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF HEMCYTABINE | 1998 |
|
RU2194711C2 |
| AZACYTIDINE ANALOGUES AND USE THEREOF | 2008 |
|
RU2488591C2 |
| AZACYTIDINE ANALOGUES AND USE THEREOF | 2008 |
|
RU2487883C2 |
| CA-IX SPECIFIC RADIOPHARMACEUTICAL AGENTS FOR TREATING AND IMAGING MALIGNANT TUMOURS | 2009 |
|
RU2539565C2 |
| MONOESTER COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2139884C1 |
| TETRAHYDROCARBAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION BASED ON SAID DERIVATIVES | 2005 |
|
RU2430088C2 |
| BIOGENIC AMINE N-ACYL DERIVATIVES ARE MODULATORS OF LIPID PEROXIDE OXIDATION, AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2093520C1 |
| 5-(CYTOSINYL-1)-1,3-OXATHIOLANES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2142462C1 |
| FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
| SUBSTITUTED DERIVATIVES OF 1, 2, 3, 4-TETRAHYDROISOQUINOLINE | 2005 |
|
RU2378257C2 |
